3 Indisputable Reasons Why AbbVie Is the Best Big Pharma Stock
What's the best big pharma stock?
Of course, "best" can mean different things to different people. But with stocks, there are key metrics that can be used to determine which are better than others. And if one stock clearly dominates in several of those metrics, it has a strong argument in being named as the best.
AbbVie (NYSE: ABBV) is such a stock. On the measurements that count the most for investors, it outperforms every other major drugmaker in its peer group. Here are three indisputable reasons why AbbVie ranks as the best big pharma stock on the market right now.
Source: Fool.com
AbbVie Inc. Stock
€153.08
1.140%
The stock is an absolute favorite of our community with 22 Buy predictions and no Sell predictions.
As a result the target price of 175 € shows a slightly positive potential of 14.32% compared to the current price of 153.08 € for AbbVie Inc..
